Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tecovirimat sub-protocol for hospitalized patients with mpox or smallpox
jRCTs031240110Recruiting
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of tecovirimat in mpox and smallpox (4 arms), sponsored by Japan Agency for Medical Research and Development. Primary endpoint: Skin lesion PCR negativity at day 14. Started Jan 2026; status: recruiting.
02
Drugs
tecovirimat
03
Conditions
mpoxsmallpox
Beyond the preview
Go deeper on jRCTs031240110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031240110.